Home » Healthcare » North America Platelet Rich Plasma (PRP) Market

North America Platelet Rich Plasma (PRP) Market

North America Platelet Rich Plasma (PRP) Market By Type (Pure Platelet Rich Plasma (P-PRP), Leukocyte-Rich Platelet Rich Plasma (L-PRP), Leukocyte-Platelet-Rich Fibrin (L-PRF)); By Origin (Autologous, Homologous, Allogeneic); By Application (Orthopedic and Spinal Surgery, Cosmetic Surgery and Aesthetics, Neurosurgery, General Surgery, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
North America Platelet Rich Plasma (PRP) Market Size 2023	USD 323.10 million
North America Platelet Rich Plasma (PRP) Market, CAGR	12.61%
North America Platelet Rich Plasma (PRP) Market Size 2032	USD 835.50 million

Market Overview:

The North America Platelet Rich Plasma (PRP) Market is projected to grow from USD 323.10 million in 2024 to an estimated USD 835.50 million by 2032, with a compound annual growth rate (CAGR) of 12.61% from 2024 to 2032.

Several factors are propelling the growth of the PRP market in North America. The increasing preference for non-surgical aesthetic procedures, such as facial rejuvenation and hair restoration, has heightened the demand for PRP treatments. These procedures are increasingly viewed as safe, effective, and low-risk alternatives to traditional surgery. Additionally, the rising prevalence of musculoskeletal disorders and sports-related injuries has led to a greater adoption of PRP therapies in orthopedics and rehabilitation. As athletes and older populations seek treatments with shorter recovery times, PRP serves as an attractive solution. Technological advancements in PRP preparation and application techniques have also improved treatment outcomes, further boosting market growth. These innovations have enhanced the precision, efficiency, and safety of PRP procedures. Moreover, the growing acceptance of regenerative medicine and the desire for natural healing methods are influencing both patient and provider choices, contributing to the market’s expansion.

North America, particularly the United States, holds a dominant position in the global PRP market. The U.S. benefits from a well-established healthcare infrastructure, high disposable income, and a strong inclination towards cosmetic procedures, all of which support the widespread adoption of PRP treatments. The increasing emphasis on self-care and personal wellness has also contributed to the demand for minimally invasive aesthetic solutions. Canada also contributes significantly to the market, with increasing utilization of PRP in both aesthetic and medical applications. The Canadian healthcare system, along with the rising trend of personalized medicine, supports a favorable environment for PRP therapies. The regulatory environment in North America, while stringent, ensures the safety and efficacy of PRP therapies, fostering consumer confidence. However, challenges such as the need for standardized protocols and the varying levels of insurance coverage for PRP treatments may impact market growth to some extent.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights:

The North America Platelet Rich Plasma (PRP) Market is projected to grow from USD 323.10 million in 2024 to USD 835.50 million by 2032, with a CAGR of 12.61%.
The global Platelet Rich Plasma (PRP) market is projected to grow from USD 729.75 million in 2024 to USD 1,895.64 million by 2032, at a CAGR of 12.67% during the forecast period.
Growing preference for non-surgical aesthetic procedures, including facial rejuvenation and hair restoration, is driving the demand for PRP therapies.
Rising prevalence of musculoskeletal disorders and sports-related injuries is increasing the adoption of PRP in orthopedic treatments and rehabilitation.
Technological advancements in PRP preparation techniques, such as improved centrifugation methods, are enhancing the efficacy and safety of treatments.
The increasing awareness of regenerative medicine is contributing to the rising popularity of PRP as a natural, non-pharmaceutical treatment option.
Regulatory challenges, including the lack of standardized protocols and unclear approval processes, hinder wider adoption and consistency in treatment outcomes.
Limited insurance coverage for PRP procedures, particularly in aesthetic applications, creates affordability concerns, restricting broader market access.

Report scoope

This report segments the North America Platelet Rich Plasma (PRP) Market as follow

Market Drivers:

Growing Demand for Non-Surgical Aesthetic Procedures

The North America Platelet Rich Plasma (PRP) Market is experiencing significant growth due to the increasing preference for non-surgical aesthetic treatments. Patients increasingly seek alternatives to traditional cosmetic surgeries, drawn to the minimally invasive nature and shorter recovery periods of PRP therapies. PRP is used in various aesthetic procedures, including facial rejuvenation and hair restoration, offering patients natural, safe, and effective outcomes without the need for incisions or long recovery times. The rising awareness of these benefits has expanded the adoption of PRP in dermatology and aesthetic clinics, further fueling market demand.

Rising Prevalence of Musculoskeletal Disorders and Sports Injuries

A key driver of growth in the North America Platelet Rich Plasma (PRP) Market is the rising prevalence of musculoskeletal disorders and sports injuries. With an aging population and an active sports culture, the demand for regenerative treatments like PRP is increasing. PRP is being widely used in orthopedic applications to treat conditions such as osteoarthritis, tendonitis, and ligament injuries. These therapies offer patients an effective alternative to traditional treatments, such as surgery, which typically requires long recovery times. PRP’s ability to accelerate healing and promote tissue regeneration has made it a preferred choice for treating musculoskeletal injuries.

For example, a study cited in the National Institutes of Health database found that athletes treated with PRP returned to play in an average of 21.1 days, compared to 25 days for those receiving standard conservative therapy, demonstrating a statistically significant improvement in recovery speed.

Technological Advancements in PRP Therapy

Technological advancements have played a pivotal role in the growth of the North America Platelet Rich Plasma (PRP) Market. Improvements in PRP preparation techniques and equipment have led to more efficient and reliable treatment processes. New innovations in PRP centrifugation, which enhance platelet concentration and purity, have improved the outcomes of treatments. These advancements have made PRP therapy more accessible, safe, and effective, leading to higher adoption rates among both healthcare providers and patients. As the technology continues to evolve, the market will likely see even greater uptake across various medical and aesthetic sectors.

For example, Arthrex’s Angel System allows clinicians to customize platelet and plasma concentrations, resulting in tailored treatments for specific patient needs.

Increasing Awareness of Regenerative Medicine

The growing acceptance and awareness of regenerative medicine have significantly contributed to the expansion of the North America Platelet Rich Plasma (PRP) Market. PRP therapy, a cornerstone of regenerative medicine, is gaining recognition as an effective treatment for various conditions, including chronic injuries and skin aging. The natural healing properties of PRP, which harness the body’s own platelets to accelerate tissue repair, appeal to patients seeking safe, non-pharmaceutical treatments. As more clinical studies support the efficacy of PRP in both medical and aesthetic applications, the public’s confidence in these treatments continues to rise, fostering market growth

Market Trends:

Expansion of PRP Applications in Aesthetic Treatments

A significant trend in the North America Platelet Rich Plasma (PRP) Market is the increasing use of PRP in a variety of aesthetic treatments. Initially popular for its application in hair restoration, PRP is now being used in a wider range of cosmetic procedures, including facial rejuvenation, skin tightening, and under-eye treatments. The desire for non-invasive, natural-looking results has prompted patients to seek PRP therapy as an alternative to more invasive surgical procedures. This trend is contributing to the growing popularity of PRP among dermatologists and cosmetic surgeons, and the market is expected to continue expanding in response to consumer demand for effective, minimally invasive aesthetic treatments.

For example, MetropolitanMD in Chicago offers PRP treatments for facial rejuvenation and hair loss, highlighting that PRP can stimulate collagen production, improve skin elasticity, and activate dormant hair follicles, leading to enhanced skin texture and hair growth for both men and women.

Growing Popularity of PRP for Sports Medicine and Orthopedic Applications

Another prominent trend in the North America Platelet Rich Plasma (PRP) Market is the increasing adoption of PRP therapies in sports medicine and orthopedic applications. PRP is being increasingly used for treating musculoskeletal injuries, including tendonitis, osteoarthritis, and ligament sprains, particularly among athletes. The natural healing properties of PRP, along with its ability to accelerate recovery and reduce pain, are key factors in its growing use for injury recovery. Sports professionals and active individuals are seeking alternatives to traditional surgery and long rehabilitation periods, positioning PRP as an attractive option for faster healing and improved recovery times.

Advancements in PRP Technologies and Treatment Protocols

Technological advancements in PRP preparation and administration are shaping a key trend in the North America Platelet Rich Plasma (PRP) Market. New centrifugation technologies, improved equipment, and enhanced protocols have made PRP treatments more efficient, consistent, and effective. These innovations have led to higher concentrations of platelets and growth factors, increasing the therapeutic potential of PRP. As the technology evolves, healthcare providers can offer more tailored treatments, enhancing patient outcomes and driving the demand for PRP in various medical applications. Ongoing research into optimizing PRP protocols is expected to further bolster market growth.

For instance, the ProGen PRP™ Advantage system, manufactured in the U.S. and cleared by the FDA, features a single-spin process that yields high-quality PRP for immediate use in clinical settings, ensuring safety and consistency.

Rising Consumer Demand for Natural and Regenerative Therapies

There is a growing trend in the North America Platelet Rich Plasma (PRP) Market toward the increasing consumer demand for natural and regenerative therapies. PRP’s ability to harness the body’s own healing properties appeals to patients seeking treatments that do not involve synthetic drugs or invasive procedures. As awareness around regenerative medicine increases, more individuals are opting for PRP as a safe and effective treatment option for chronic injuries, skin aging, and hair loss. This shift toward natural therapies is driving greater interest in PRP among both patients and medical professionals, contributing to the expanding market.

Market Challenges Analysis:

Regulatory and Standardization Challenges

One of the key challenges in the North America Platelet Rich Plasma (PRP) Market is the lack of standardized protocols and inconsistent regulations. While PRP therapy is widely used across various medical and aesthetic fields, there is no uniform standard for its preparation and application. Different clinics and practitioners may use varying methods for centrifugation and platelet concentration, leading to discrepancies in treatment outcomes. The absence of standardized guidelines from regulatory bodies can create confusion for patients and healthcare providers, potentially affecting patient safety and treatment efficacy. Regulatory agencies, such as the FDA, have not fully classified PRP as a medical product, which leads to a lack of clarity on its approval process. This regulatory ambiguity hampers market growth by limiting wider adoption and creating inconsistencies in quality control.

For instance, PRP preparation systems are brought to market in the United States through the FDA’s 510(k) pathway, which only requires that new devices are “substantially equivalent” to an already cleared predicate device-typically for mixing with bone graft materials in orthopedics.

Insurance Coverage and Affordability Concerns

Another significant challenge facing the North America Platelet Rich Plasma (PRP) Market is the limited insurance coverage for PRP treatments, particularly for aesthetic applications. Many insurance companies do not cover PRP procedures, viewing them as elective or cosmetic in nature, which increases the out-of-pocket expenses for patients. This lack of coverage, coupled with the relatively high cost of PRP treatments, can make them inaccessible to a significant portion of the population. While the demand for PRP continues to rise, the affordability issue may hinder its widespread adoption, especially among individuals with lower income or without sufficient healthcare coverage. This limitation impacts the market’s potential, especially in the growing aesthetic segment, where many potential patients may be deterred by the cost.

Market Opportunities:

The North America Platelet Rich Plasma (PRP) Market holds significant opportunities in the growing field of regenerative medicine and orthopedics. As more patients seek non-surgical treatment options for musculoskeletal injuries, PRP offers an effective solution for conditions like tendonitis, osteoarthritis, and ligament sprains. The increasing demand for minimally invasive therapies in sports medicine and orthopedics presents a substantial growth opportunity for PRP. With more clinical evidence supporting its efficacy, PRP therapy can capture a larger share of the orthopedic market as healthcare providers look for alternatives to traditional surgery. As the adoption of regenerative treatments continues to grow, PRP is well-positioned to expand its applications across various therapeutic areas.

There is a clear opportunity in the North America Platelet Rich Plasma (PRP) Market driven by the rising demand for non-invasive aesthetic treatments. Patients increasingly prefer PRP for facial rejuvenation, hair restoration, and skin rejuvenation due to its natural and minimal downtime benefits. The growing trend toward personalized beauty treatments also enhances the appeal of PRP, as it provides a tailored approach using the patient’s own biological material. As more clinics adopt PRP for cosmetic procedures and with the expanding focus on wellness, the aesthetic applications of PRP offer a promising opportunity for market growth. With rising consumer awareness and an increasing shift toward preventive care, the demand for PRP in aesthetics is expected to accelerate.

Market Segmentation Analysis:

By Type

The North America Platelet Rich Plasma (PRP) Market is segmented by type into Pure Platelet Rich Plasma (P-PRP), Leukocyte-Rich Platelet Rich Plasma (L-PRP), and Leukocyte-Platelet-Rich Fibrin (L-PRF). Among these, P-PRP is widely used due to its high concentration of platelets and growth factors, making it effective for musculoskeletal and cosmetic procedures. L-PRP, which contains a higher concentration of white blood cells, is commonly used for inflammatory conditions, while L-PRF, with a higher fibrin content, is favored for its longer-lasting effects in regenerative medicine and tissue healing.

By Origin

The market is also segmented by origin, including autologous, homologous, and allogeneic PRP. Autologous PRP, derived from the patient’s own blood, dominates the market due to its safety profile and minimal risk of adverse reactions. Homologous and allogeneic PRP, sourced from donors, are gaining traction in specific clinical applications but face regulatory and ethical concerns.

By Application

In terms of application, the North America Platelet Rich Plasma (PRP) Market is divided into orthopedic and spinal surgery, cosmetic surgery and aesthetics, neurosurgery, general surgery, and others. Orthopedic applications, including joint regeneration and tendon repair, lead the market, followed by cosmetic procedures like facial rejuvenation and hair restoration. PRP’s use in neurosurgery and general surgery is also expanding as more research supports its therapeutic benefits.

Segmentation:

By Type:

Pure Platelet Rich Plasma (P-PRP)
Leukocyte-Rich Platelet Rich Plasma (L-PRP)
Leukocyte-Platelet-Rich Fibrin (L-PRF)

By Origin:

Autologous
Homologous
Allogeneic

By Application:

Orthopedic and Spinal Surgery
Cosmetic Surgery and Aesthetics
Neurosurgery
General Surgery
Others

Regional Analysis:

The North America Platelet Rich Plasma (PRP) Market is predominantly led by the United States, which holds the largest market share in the region, accounting for over 75% of the overall market. The U.S. benefits from a well-established healthcare infrastructure, high consumer awareness, and a strong demand for both medical and aesthetic PRP applications. The growing prevalence of musculoskeletal disorders, along with the popularity of non-invasive aesthetic treatments, continues to drive the adoption of PRP therapies. With increasing healthcare expenditure and technological advancements in PRP preparation and administration, the U.S. is expected to maintain its dominant position throughout the forecast period. The market in the U.S. is also bolstered by a large number of clinics offering PRP for sports injuries, cosmetic procedures, and chronic conditions.

Canada represents a growing segment of the North America Platelet Rich Plasma (PRP) Market, with a market share of approximately 15%. The demand for PRP therapies in Canada is increasing, particularly in orthopedic applications and aesthetic treatments. Canada’s healthcare system and regulatory environment ensure that PRP therapies are accessible and safe, contributing to rising adoption rates. The Canadian market is seeing greater utilization of PRP for non-invasive cosmetic procedures, such as skin rejuvenation and hair restoration. Furthermore, the increasing awareness of regenerative medicine and its benefits is expected to drive further growth in the Canadian market.

Mexico’s share in the North America Platelet Rich Plasma (PRP) Market is relatively smaller but holds potential for future growth. The market in Mexico is expanding due to increasing healthcare investments and the rising demand for aesthetic procedures, including PRP hair restoration and facial rejuvenation. The growing popularity of regenerative treatments in sports medicine and orthopedics is also contributing to market expansion. As healthcare infrastructure improves and PRP becomes more widely available, the Mexican market is expected to experience rapid growth in the coming years. The increasing adoption of PRP therapies in both medical and aesthetic sectors will play a significant role in shaping the future of the market in Mexico.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis:

ProGen PRP
MedGeneRx
NewGen Biologics
InGeneron
RegenOMedix

Competitive Analysis:

The North America Platelet Rich Plasma (PRP) Market is highly competitive, with numerous players offering innovative solutions for both medical and aesthetic applications. Key market participants include companies like Arthrex, Inc., EmCyte Corporation, Regen Lab, and Prisma Labs, all of which provide advanced PRP systems and kits. These companies focus on product differentiation through technological innovations, such as improved centrifugation techniques and automation systems, to enhance the efficiency and effectiveness of PRP treatments. The growing demand for PRP in orthopedics, sports medicine, and cosmetic surgery drives these companies to continuously improve product offerings. Strategic partnerships, mergers, and acquisitions are common, as industry leaders aim to expand their market reach and improve their competitive positions. As the market evolves, companies must also address regulatory challenges and maintain product safety standards to stay competitive.

Recent Developments:

In February 2024, Crown Laboratories, through its division Crown Aesthetics, completed the acquisition of Healeon’s assets and technology, a move that directly enhances its position in the Platelet-Rich Plasma (PRP) sector in North America. This acquisition is particularly significant for the ProGen PRP Eclipse brand, which is recognized as the first PRP brand to qualify and quantify autologous exosomes in its product. The strategic acquisition is set to accelerate Crown’s product development and broaden its reach in the PRP market, allowing for rapid entry into new markets and expanding access to innovative PRP devices.
In January 2024, Arthrex showcased the use of its ACP Max system, which is designed for creating highly concentrated platelet-rich plasma (PRP) with low neutrophil content. This demonstration highlighted Arthrex’s commitment to advancing PRP technology for improved patient outcomes in regenerative medicine and orthopedic applications
In October 2024, Terumo Blood and Cell Technologies (Terumo BCT) entered a 10-year partnership with the Sanquin Blood Supply Foundation in the Netherlands to automate the country’s blood processing facilities using the Reveos™ Automated Blood Processing System. This agreement aims to enhance efficiency and increase the production of essential blood products, including platelets and plasma, by reducing manual steps and streamlining operations.

Market Concentration & Characteristics:

The North America Platelet Rich Plasma (PRP) Market exhibits moderate concentration, with a few dominant players leading the industry. Companies such as Arthrex, EmCyte Corporation, and Regen Lab hold significant market shares, driving innovation and product development. The market is characterized by technological advancements in PRP preparation and application, which are crucial for enhancing treatment efficacy and outcomes. Competitive dynamics are influenced by the need for continuous research and development, regulatory compliance, and increasing consumer demand for non-invasive treatments. Market participants focus on expanding their product portfolios through strategic partnerships and acquisitions. While the market remains concentrated in key regions like the United States, it is growing steadily in Canada and Mexico, driven by expanding healthcare infrastructure and rising consumer awareness of PRP therapies. This trend is expected to continue as demand for both medical and aesthetic applications increases.

Report Coverage:

The research report offers an in-depth analysis based on type, origin, and application. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

The North America Platelet Rich Plasma (PRP) Market is expected to grow steadily due to increasing demand for non-invasive aesthetic treatments.
Advancements in PRP technology and centrifugation techniques will enhance treatment outcomes and improve patient safety.
The aging population in North America will drive the demand for PRP therapies, particularly in orthopedic and musculoskeletal treatments.
Expanding clinical evidence supporting PRP’s efficacy will foster greater adoption in both medical and aesthetic sectors.
The rise of regenerative medicine will further boost the use of PRP for tissue repair and healing.
The popularity of minimally invasive procedures in cosmetic dermatology will increase PRP’s share in the aesthetic market.
The regulatory environment will evolve, providing clearer guidelines for PRP products and ensuring safer practices.
Insurance coverage for PRP treatments may expand, improving accessibility for a broader patient base.
New market entrants and competition will drive innovation, leading to better, more efficient PRP systems.
Increased consumer awareness of PRP benefits will contribute to the broader adoption of these therapies across North America.

CHAPTER NO. 1 : INTRODUCTION 17

1.1.1. Report Description 17

Purpose of the Report 17

USP & Key Types 17

1.1.2. Key Benefits for Stakeholders 17

1.1.3. Target Audience 18

1.1.4. Report Scope 18

CHAPTER NO. 2 : EXECUTIVE SUMMARY 19

2.1. North America Platelet Rich Plasma (PRP) Market Snapshot 19

2.1.1. North America Platelet Rich Plasma (PRP) Market, 2018 – 2032 (USD Million) 20

CHAPTER NO. 3 : NORTH AMERICA PLATELET RICH PLASMA (PRP) MARKET – INDUSTRY ANALYSIS 21

3.1. Introduction 21

3.2. Market Drivers 22

3.2.1. Growth of Wellness and Spa Industries Offering Platelet Rich Plasma 22

3.2.2. Advancements in PRP Storage and Preservation Technologies 23

3.3. Market Restraints 24

3.3.1. Risk of Infection or Complications from Improper Handling 24

3.4. Market Opportunities 25

3.4.1. Market Opportunity Analysis 25

3.5. Porter’s Five Forces Analysis 26

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 27

4.1. Company Market Share Analysis – 2023 27

4.1.1. North America Platelet Rich Plasma (PRP) Market: Company Market Share, by Revenue, 2024 27

4.1.2. North America Platelet Rich Plasma (PRP) Market: Top 6 Company Market Share, by Revenue, 2024 27

4.1.3. North America Platelet Rich Plasma (PRP) Market: Top 3 Company Market Share, by Revenue, 2024 28

4.2. North America Platelet Rich Plasma (PRP) Market Company Revenue Market Share, 2024 29

4.3. Company Assessment Metrics, 2024 30

4.3.1. Stars 30

4.3.2. Emerging Leaders 30

4.3.3. Pervasive Players 30

4.3.4. Participants 30

4.4. Start-ups /SMEs Assessment Metrics, 2024 30

4.4.1. Progressive Companies 30

4.4.2. Responsive Companies 30

4.4.3. Dynamic Companies 30

4.4.4. Starting Blocks 30

4.5. Strategic Developments 31

4.5.1. Acquisitions & Mergers 31

New Product Launch 31

North America Expansion 31

4.6. Key Players Product Matrix 32

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 33

5.1. PESTEL 33

5.1.1. Political Factors 33

5.1.2. Economic Factors 33

5.1.3. Social Factors 33

5.1.4. Technological Factors 33

5.1.5. Environmental Factors 33

5.1.6. Legal Factors 33

5.2. Adjacent Market Analysis 33

CHAPTER NO. 6 : NORTH AMERICA PLATELET RICH PLASMA (PRP) MARKET – BY TYPE SEGMENT ANALYSIS 34

6.1. North America Platelet Rich Plasma (PRP) Market Overview, by Type Segment 34

6.1.1. North America Platelet Rich Plasma (PRP) Market Revenue Share, By Type, 2023 & 2032 35

6.1.2. North America Platelet Rich Plasma (PRP) Market Attractiveness Analysis, By Type 36

6.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 36

6.1.4. North America Platelet Rich Plasma (PRP) Market Revenue, By Type, 2018, 2023, 2027 & 2032 37

6.2. Pure Platelet Rich Plasma (P-PRP) 38

6.3. Leukocyte-Rich Platelet Rich Plasma (L-PRP) 39

6.4. Leukocyte-Platelet-Rich Fibrin (L-PRF) 40

CHAPTER NO. 7 : NORTH AMERICA PLATELET RICH PLASMA (PRP) MARKET – BY ORIGIN SEGMENT ANALYSIS 41

7.1. North America Platelet Rich Plasma (PRP) Market Overview, by Origin Segment 41

7.1.1. North America Platelet Rich Plasma (PRP) Market Revenue Share, By Origin, 2023 & 2032 42

7.1.2. North America Platelet Rich Plasma (PRP) Market Attractiveness Analysis, By Origin 43

7.1.3. Incremental Revenue Growth Opportunity, by Origin, 2024 – 2032 43

7.1.4. North America Platelet Rich Plasma (PRP) Market Revenue, By Origin, 2018, 2023, 2027 & 2032 44

7.2. Autologous 45

7.3. Homologous 46

7.4. Allogeneic 47

CHAPTER NO. 8 : NORTH AMERICA PLATELET RICH PLASMA (PRP) MARKET – BY APPLICATION SEGMENT ANALYSIS 48

8.1. North America Platelet Rich Plasma (PRP) Market Overview, by Application Segment 48

8.1.1. North America Platelet Rich Plasma (PRP) Market Revenue Share, By Application, 2023 & 2032 49

8.1.2. North America Platelet Rich Plasma (PRP) Market Attractiveness Analysis, By Application 50

8.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 50

8.1.4. North America Platelet Rich Plasma (PRP) Market Revenue, By Application, 2018, 2023, 2027 & 2032 51

8.2. Orthopedic and Spinal Surgery 52

8.3. Cosmetic Surgery and Aesthetics 53

8.4. Neurosurgery 54

8.5. General Surgery 55

8.6. Others 56

CHAPTER NO. 9 : PLATELET RICH PLASMA (PRP) MARKET – NORTH AMERICA 57

9.1. North America 57

9.1.1. Key Highlights 57

9.1.2. North America Platelet Rich Plasma (PRP) Market Revenue, By Country, 2018 – 2023 (USD Million) 58

9.1.3. North America Platelet Rich Plasma (PRP) Market Revenue, By Type, 2018 – 2023 (USD Million) 59

9.1.4. North America Platelet Rich Plasma (PRP) Market Revenue, By Origin, 2018 – 2023 (USD Million) 60

9.1.5. North America Platelet Rich Plasma (PRP) Market Revenue, By Application, 2018 – 2023 (USD Million) 61

9.2. U.S. 62

9.3. Canada 62

9.4. Mexico 62

CHAPTER NO. 10 : COMPANY PROFILES 63

10.1. ProGen PRP 63

10.1.1. Company Overview 63

10.1.2. Product Portfolio 63

10.1.3. Swot Analysis 63

10.1.4. Business Strategy 64

10.1.5. Financial Overview 64

10.2. MedGeneRx 65

10.3. NewGen Biologics 65

10.4. InGeneron 65

10.5. RegenOMedix 65

10.6. Company 6 65

10.7. Company 7 65

10.8. Company 8 65

10.9. Company 9 65

10.10. Company 10 6

List of Figures

FIG NO. 1. North America Platelet Rich Plasma (PRP) Market Revenue, 2018 – 2032 (USD Million) 20

FIG NO. 2. Porter’s Five Forces Analysis for North America Platelet Rich Plasma (PRP) Market 26

FIG NO. 3. Company Share Analysis, 2024 27

FIG NO. 4. Company Share Analysis, 2024 27

FIG NO. 5. Company Share Analysis, 2024 28

FIG NO. 6. North America Platelet Rich Plasma (PRP) Market – Company Revenue Market Share, 2024 29

FIG NO. 7. North America Platelet Rich Plasma (PRP) Market Revenue Share, By Type, 2023 & 2032 35

FIG NO. 8. Market Attractiveness Analysis, By Type 36

FIG NO. 9. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 36

FIG NO. 10. North America Platelet Rich Plasma (PRP) Market Revenue, By Type, 2018, 2023, 2027 & 2032 37

FIG NO. 11. North America Platelet Rich Plasma (PRP) Market for Pure Platelet Rich Plasma (P-PRP), Revenue (USD Million) 2018 – 2032 38

FIG NO. 12. North America Platelet Rich Plasma (PRP) Market for Leukocyte-Rich Platelet Rich Plasma (L-PRP), Revenue (USD Million) 2018 – 2032 39

FIG NO. 13. North America Platelet Rich Plasma (PRP) Market for Leukocyte-Platelet-Rich Fibrin (L-PRF), Revenue (USD Million) 2018 – 2032 40

FIG NO. 14. North America Platelet Rich Plasma (PRP) Market Revenue Share, By Origin, 2023 & 2032 42

FIG NO. 15. Market Attractiveness Analysis, By Origin 43

FIG NO. 16. Incremental Revenue Growth Opportunity by Origin, 2024 – 2032 43

FIG NO. 17. North America Platelet Rich Plasma (PRP) Market Revenue, By Origin, 2018, 2023, 2027 & 2032 44

FIG NO. 18. North America Platelet Rich Plasma (PRP) Market for Autologous, Revenue (USD Million) 2018 – 2032 45

FIG NO. 19. North America Platelet Rich Plasma (PRP) Market for Homologous, Revenue (USD Million) 2018 – 2032 46

FIG NO. 20. North America Platelet Rich Plasma (PRP) Market for Allogeneic, Revenue (USD Million) 2018 – 2032 47

FIG NO. 21. North America Platelet Rich Plasma (PRP) Market Revenue Share, By Application, 2023 & 2032 49

FIG NO. 22. Market Attractiveness Analysis, By Application 50

FIG NO. 23. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 50

FIG NO. 24. North America Platelet Rich Plasma (PRP) Market Revenue, By Application, 2018, 2023, 2027 & 2032 51

FIG NO. 25. North America Platelet Rich Plasma (PRP) Market for Orthopedic and Spinal Surgery, Revenue (USD Million) 2018 – 2032 52

FIG NO. 26. North America Platelet Rich Plasma (PRP) Market for Cosmetic Surgery and Aesthetics, Revenue (USD Million) 2018 – 2032 53

FIG NO. 27. North America Platelet Rich Plasma (PRP) Market for Neurosurgery, Revenue (USD Million) 2018 – 2032 54

FIG NO. 28. North America Platelet Rich Plasma (PRP) Market for General Surgery, Revenue (USD Million) 2018 – 2032 55

FIG NO. 29. North America Platelet Rich Plasma (PRP) Market for Others, Revenue (USD Million) 2018 – 2032 56

FIG NO. 30. North America Platelet Rich Plasma (PRP) Market Revenue, 2018 – 2032 (USD Million) 57

List of Tables

TABLE NO. 1. : North America Platelet Rich Plasma (PRP) Market: Snapshot 20

TABLE NO. 2. : Drivers for the North America Platelet Rich Plasma (PRP) Market: Impact Analysis 23

TABLE NO. 3. : Restraints for the North America Platelet Rich Plasma (PRP) Market: Impact Analysis 25

TABLE NO. 4. : North America Platelet Rich Plasma (PRP) Market Revenue, By Country, 2018 – 2023 (USD Million) 59

TABLE NO. 5. : North America Platelet Rich Plasma (PRP) Market Revenue, By Country, 2024 – 2032 (USD Million) 59

TABLE NO. 6. : North America Platelet Rich Plasma (PRP) Market Revenue, By Type, 2018 – 2023 (USD Million) 60

TABLE NO. 7. : North America Platelet Rich Plasma (PRP) Market Revenue, By Type, 2024 – 2032 (USD Million) 60

TABLE NO. 8. : North America Platelet Rich Plasma (PRP) Market Revenue, By Origin, 2018 – 2023 (USD Million) 61

TABLE NO. 9. : North America Platelet Rich Plasma (PRP) Market Revenue, By Origin, 2024 – 2032 (USD Million) 61

TABLE NO. 10. : North America Platelet Rich Plasma (PRP) Market Revenue, By Application, 2018 – 2023 (USD Million) 62

TABLE NO. 11. : North America Platelet Rich Plasma (PRP) Market Revenue, By Application, 2024 – 2032 (USD Million) 62

Frequently Asked Questions

What is the current size of the North America Platelet Rich Plasma (PRP) Market?

The North America Platelet Rich Plasma (PRP) Market is projected to grow from USD 323.10 million in 2024 to an estimated USD 835.50 million by 2032, with a CAGR of 12.61% from 2024 to 2032.

What factors are driving the growth of the North America Platelet Rich Plasma (PRP) Market?

Key drivers include the increasing preference for non-surgical aesthetic procedures, the rising prevalence of musculoskeletal disorders, technological advancements in PRP techniques, and growing acceptance of regenerative medicine.

What are some challenges faced by the North America Platelet Rich Plasma (PRP) Market?

Challenges include a lack of standardized protocols, varying insurance coverage, and regulatory uncertainties surrounding PRP treatments.

Who are the major players in the North America Platelet Rich Plasma (PRP) Market?

Major players include Arthrex, Inc., EmCyte Corporation, Regen Lab, and Prisma Labs, all of which offer advanced PRP systems for various medical and aesthetic applications.

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$10699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –